Abstract
Schönlein-Henoch syndrome is a form of systemic small-vessel vasculitis,characterised by vascular and/or mesangial immunoglobulin A1 deposits. The main clinical manifestations are vascular purpura, predominating on the lower limbs, and articular, gastrointestinal and renal symptoms. Pulmonary, cardiac, genital and neurological symptoms have also be observed. The syndrome usually affects children, whereas it is rare in adults.
The frequency of renal involvement varies between individual studies (from 20 to 100%). Renal manifestations are usually mild and transient, although chronic nephropathies may occur. Overall, an estimated 2% of children with Schönlein-Henoch purpura progress to renal failure and up to 20% of children with nephritis treated in specialised centres require haemodialysis. The renal prognosis appears to be worse in adults. Aetiological investigations are required, as a triggering factor is found in approximately half the patients (e.g. viral, bacterial and parasitic infections, drugs, toxins, systemic diseases and cancer).
Dapsone has beneficial effects on cutaneous, gastrointestinal and articular manifestations in adults, especially those with chronic forms. Corticosteroids may be useful for refractory abdominal pain. Methylprednisolone pulse therapy, immunosuppressive drugs (e.g. cyclophosphamide and azathioprine), plasma exchange and polyclonal immunoglobulin therapy are beneficial in very rare life-threatening forms of the disease and in rare instances where renal function is compromised.
References
Jennette C, Falk R, Andrassy R, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–92
Heberden W. Commentarii di morborium-historia et curatione. London: Payne, 1802
Schönlein JL. Allgemeine und specielle Pathologie und Therapie. Würzburg: Etlinger, 1832: 41
Henoch E. Verhandkungen ärztlicher Gesellschaffen. Berliner Klin Wochenschr 1868; 5: 517
Hierholzer J, Hierholzer C, Hierholzer K. Johann Lukas Schönlein and his contribution to nephrology and medicine. Am J Nephrol 1994; 14: 467–72
Henoch E. Neunter Absschnitt. Die hämorrhagische Diathese-purpura. In: Vorlesungen über Kinderkrankheiten. Berlin: Hirschwald, 1899: 847
Couillet D, Cribier B. Historique et nosologie du purpura rhumatoïde. Ann Dermatol Venereol 1998; 125: 141–8
Osler W. The visceral lesions of purpura and allied conditions. BMJ 1914; 1:517–27
Gougerot H, Dupperat B. The nodular dermal allergides of Gougerot. Br J Dermatol 1954; 66: 283–6
Chevalier P. Le purpura inflammatoire primitif benin chronique. Sem Hop 1934; 9: 265–76
Gairdner D. The Schönlein-Henoch syndrome (anaphylactoid purpura). Q JMed 1948; 17: 95–22
Cream J, Gumpel J, Peachey R. Schönlein-Henoch purpura in the adult. Q J Med 1970; 39: 461–84
Berger J. IgA glomerular deposits in renal disease. Transplant Proc 1969; 1: 939–44
Baart de la Faille-Kuyper EH, Kater L, Kooiker CJ, et al. IgA deposits in cutaneous blood-vessels walls and mesangium in Henoch-Schönlein purpura. Lancet 1973; i: 892–3
Conley ME, Cooper M, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J Clin invest 1980; 66: 1432–6
Stevenson J, Leong L, Cohen A, et al. Henoch-Schönlein purpura: simultaneous demonstration of IgA deposits in involved skin,, intestine and kidney. Arch Pathol Lab Med 1982; 106: 192–5
Clarkson A, Woodroffe A, Bannister K, et al. The syndrome of IgA nephropathy. Clin Nephrol 1984; 21:7–14
Saulsbury F. Henoch-Schönlein purpura in children. Medicine 1999; 78: 395–409
Yeng M. Henoch-Schönlein purpura. Br J Dermatol 1985; 112: 235–40
Rostoker G. Therapy of IgA nephritis. Biodrugs 1998; 4: 279–301
Al Sheyyab M, El-Shanti H, Ajlouni S, et al. Henoch-Schönlein purpura clinical experience and contemplations on a streptococcal association. J Trop Pediatr 1996; 42: 200–3
Beauvais C, Kaplan G, Mougenot B, et al. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis 1993; 52: 61–2
Aram H. Henoch-Schönlein purpura induced by chlorpromazine. J Am Acad Dermatol 1987; 17: 139–40
Birchmore D, Sweeney C, Devasmita C, et al. IgA multiple myeloma presenting as Henoch-Schönlein purpura/polyarteritis nodosa overlap syndrome. Arthritis Rheum 1996; 39: 698–703
Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine 1998; 77(6): 403–18
Bosch X. Henoch-Schönlein purpura induced by losartan therapy. Arch Intern Med 1998; 158: 191–2
Flatau E, Kohn D, Schiller D, et al. Schönlein-Henoch syndrome in patients with familial mediterranean fever. Arthritis Rheum 1982; 25: 42–7
Lasseur C, Allen AC, Deminiere C, et al. Henoch-Schönlein purpura with immunoglobine A nephropathy and abnormalities of immunoglobin A in a Wiskott-Aldrich syndrome carrier. Am J Kidney Dis 1997; 29: 285–7
Sussman J, Jones JH, Almeida J, et al. Deficiency in the second component of complement associated with anaphylactoid purpura and the presence of mycoplasma in the serum. Clin Exp Immunol 1973; 14: 531–9
Jimenez A, Lopez-Trascasa M, Fontan G. Incidence of selective IgG2 in patients with vasculitis. Clin Exp Immunol 1989; 78: 149–52
Moots R, Keeling P, Morgan S. Adult Henoch-Schönlein purpura after enalapril. Lancet 1992; ii: 304–5
Patel U, Bradley J, Hamilton D. Henoch-Schönlein purpura after influenza vaccination. BMJ 1988; 296: 1800
Bywaters E, Isdale I, Kempton J. Schönlein-Henoch purpura. Evidence for a group A beta haemolytic streptococcal aetiology. Q JMed 1957; 26: 161–77
Hamidou M, Gueglio B, Cassagneau E, et al. Henoch-Schönlein purpura associated with toxocara canis infection. J Rheumatol 1999; 26: 443–5
Han B, Choi S, Shin S, et al. A case of Henoch-Schönlein purpura in disseminated tuberculosis. Korean J Intern Med 1995; 10: 54–9
Katz A, Bargman JM, Miller DC, et al. IgA nephropathy in HIV-positive patients: a new HIV-associated nephropathy? Clin Nephrol 1992; 38: 61–8
Lefrère JJ, Couroucé AM, Muller JY, et al. Human parvovirus and purpura. Lancet 1985; ii: 730
Burke D, Jellinek H. Nearly fatal case of Schönlein-Henoch syndrome following insect bite. Am J Dis Child 1954; 88: 772–4
Chevalier X, Rostoker G, Larget-Piet B, et al. Schönlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 1995; 43: 348–9
Hayem G, Gomez MJ, Grossin M, et al. Systemic vasculitis and epithelioma: a report of three cases with a literature review. Rev Rhum 1997; 64(12): 816–24
Aggarwal M, Manske C, Lynch P, et al. Henoch-Schönlein vasculitis as a manifestation of IgA-associated disease in cirrhosis. Am J Kidney Dis 1992; 20: 400–2
Padilla B, Weiss M, Kant S. Henoch-Schönlein purpura in a patient with diabetic nephropathy: case report and a review of the literature. Am J Kidney Dis 1992; 20: 191–4
Mitsuhashi H, Mitsuhashi M, Tsukada Y, et al. Henoch-Schönlein purpura in rheumatoid arthritis. J Rheumatol 1994; 21: 1138–40
Stewart M, Savage J, Bell B, et al. Long-term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatrics 1988; 147: 113–5
Nielsen H. Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand 1988; 77: 125–31
Gay C, Lavocat MP, Blanc JP. Incidence du purpura rhumatoïde de l’enfant et fréquence de la néphropathie associée dans le département de la Loire. Arch Pediat 1997; 4: 486–8
Frimat L, Bellou-Zerrouki M, Kessler M. Incidence annuelle de la néphropathie à IgA (maladie de Berger) et du purpura d’Henoch-Schönlein dans l’est de la France. Presse Med 1994; 23: 1879
Watts R, Carruthers D, Scott D. Epidemiology of systemic vasculitis: changing incidence or definition. Semin Arthritis Rheum 1995; 25: 28–34
Farley T, Gillepsie S, Rasoulpour M, et al. Epidemiology of a cluster of Henoch-Schönlein purpura. AJDC 1989; 143:798–803
Kreidberg M, Dameshek W, Latorraca R. Acute vascular (Schönlein-Henoch) purpura: an immunologic disease. N Engl J Med 1955; 253: 1014–8
Wedgwood R, Klaus M. Anaphylactoid purpura (Schönlein-Henoch syndrome): a long-term follow-up study with special reference to renal involvement. Pediatrics 1955; 16: 196–206
Derham R, Rogerson M. The Schönlein-Henoch syndrome with particular reference to renal sequelae. Arch Dis Child 1956; 31: 364–8
Allen D, Diamond L, Howell D. Anaphylactoid purpura in children (Schönlein-Henoch syndrome). Review with a follow-up of the renal complications. Am J Dis Child 1960; 99: 833–54
Sterky G, Thilen A. A study on the onset and prognosis of acute vascular purpura (the Schönlein-Henoch syndrome) in children. Acta Pediatrica 1960; 49: 217–29
Vernier R, Worthen H, Peterson R, et al. Anaphylactoid purpura: I pathology of the skin and kidney and frequency of streptococcal infection. Pediatrics 1961; 27: 181–93
Weill J, Kerber S. Le purpura rhumatoïde. Entretiens de Bichat-Medicine 1969; 415–20
Lelong M, Deroubaix P. Le purpura rhumatoïde de Schönlein-Henoch: étude de 36 observations. Lille Med 1968; 13: 307–12
Ansell B. Henoch-Schönlein purpura with particular reference to the prognosis of the renal lesion. Br J Dermatol 1970; 82: 211–5
Meadow SR, Glasgow E, White R, et al. Schönlein-Henoch nephritis. Q J Med 1972; 41: 241–58
Marchal A, Bost M, Dieterlen M, et al. Le syndrome de Schoenlein-Henoch de l’enfant. Aspects cliniques et évolutifs à propos de 100 malades. Ann Pediatr 1974; 21: 379–92
Levy M, Broyer M, Arsan A, et al. Glomerulonéphrites du purpura rhumatoïde chez l’enfant. Histoire naturelle et étude immunopathologique. Actualités néphrologiques de l’Hôpital Necker. Paris: Flammarion, 1976: 174–226
Emery H, Larter W, Schaller J. Henoch-Schönlein vasculitis. Arthritis Rheum 1977; 20Suppl. 2: 385–8
Kobayashi O, Wada H, Okawa K, et al. Schönlein-Henoch’s syndrome in children. Contrib Nephrol 1977; 4: 48–71
Koskimies O, Mir S, Rapola J, et al. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 1981; 56: 482–4
Yoshikawa N, Ito H, Yoshiya K, et al. Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course. Clin Nephrol 1987; 27: 233–7
Ilan Y, Naparstek H. Schönlein Henoch in adults and children. Semin Arthritis Rheum 1991; 21: 103–9
Zhang Y, Shen Y, Feld L, et al. Changing pattern of glomerular disease at Beijing children’s hospital. Clin Pediatrics 1994; 33: 542–7
Al Harbi N. Henoch-Schoenlein syndrome in children: experience from southern part of Saudi Arabia. East Afr Med J 1996; 73: 191–3
Astulfoni A, Casati A, Ruggeri M, et al. Syndrome di Schönlein-Henoch — considerazioni a propositi di 95 casi pedriatici. Minerva Pediatr 1996; 48: 201–8
Balmelli C, Laux-End R, Di Roco D, et al. Purpura schönlein-Henoch: verlauf bei 139 Kindern. Schweiz Med Wochenschr 1996; 126: 293–8
Blanco R, Martinez-Tobaoda V, Rodriguez-Valverde V, et al. Henoch-schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40: 859–64
Wananukul S, Watana D, Pongprasit P. Henoch-Schönlein purpura in Thailand: review of 41 children. J Med Assoc Thai 1997; 80: 686–92
Kaku Y, Nohara K, Houda S. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998; 53: 1755–9
Kumar L, Singh S, Goraya JS, et al. Henoch-Schönlein purpura: the Chandigarrh experience. Indian Pediatr 1998; 35: 19–25
Lin SJ, Huang JC. Henoch-Schönlein purpura in Chinese children and adults. Asian Pac J Allergy Immunol 1998; 16: 21–5
Hugues J, Lecomte J, Dupont M. Le purpura de Schönlein-Henoch. Étude clinique chez l’adulte. Acta Clin Belg 1958; 13: 460–77
Ballard H, Eisinger R, Gallo G. Renal manifestations of the Henoch-Schoenlein syndrome in adults. Am J Med 1970; 49: 328–35
Debray J, Krulik M, Giorgi H. Le purpura rhumatoïde (syndrome de Schönlein-Henoch) de l’adulte. A propos de 22 observations. Sem Hop 1971; 47: 1805–19
Fillastre JP, Morel-Maroger L, Richet G. Schönlein-Henoch purpura in adults. Lancet 1971; i: 1243–4
Clauvel JP, Touraine R, Bernard J. Purpura rhumatoïde de l’adulte: a propos de 22 observations. Nouv Rev Fr Hematol 1972; 12: 117–22
Bar-On H, Rosenmann E. Schoenlein-Henoch syndrome in adults. Isr J Med Sci 1972; 8: 1702–15
Sinniah R, Feng P, Chen B. Henoch-Schoenlein syndrome: a clinical and morphological study of renal biopsies. Clin Nephrol 1978; 9: 219–28
Baumelou A, Beaufils H, De Groc F, et al. IgA nephropathy in Henoch-Schönlein syndrome in adults. In: Mucosal immunity: IgA and polymorphonuclear neutrophils, Paris, 1984. Suresnes: Foundation Franco-Allemande, 1985: 195–9
Roth D, Wilz D, Theil G. Schönlein-Henoch syndrome in adults. Q J Med 1985; 55: 145–52
Lee H, Koh H, Kim M, et al. Henoch-Schoenlein nephritis in adults: aclinical and morphological study. Clin Nephrol 1986; 26: 125–30
Knight JF, Cameron JS. Henoch-Schönlein nephritis: a report of the UK glomerulonephritis registry. Nephrol Dial Transplant 1987; 2: 415–6
Faull R, Aarons I, Woodroffe A, et al. Adult Henoch-Schönlein nephritis. Aust N Z J Med 1987; 17: 396–401
Fogazzi G, Pasqualli S, Moriggi M, et al. Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol 1989; 31: 60–6
Michel B, Hunder G, Bloch D, et al. Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the two disorders. J Rheumatol 1992; 19: 721–8
Küster S, Andrassy K, Waldherr R, et al. Contrasting clinical course of Henoch-Schönlein purpura in younger and elderly patients. Contrib Nephrol 1993; 105: 93–7
Lasseur C, Combe C, Rispal P, et al. Purpura rhumatoïde de l’adulte. A propos de 40 observations. Rev Med Interne 1996; 17: 381–9
Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, et al. Schönlein-Henoch purpura in adult patients: predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. Arch Dermatol 1997; 133: 438–42
Cabane J, Monteil D, Wattiaux MJ, et al. Purpura Rhumatoïde de l’adulte. Le Concours Médical 1997; 119(15): 1088–95
Janos N. Az endoszkopia Jelentösegé a Schönlein-Henoch purpura. Orv Hetilap 1997; 138: 2169–73
Magro C, Crowson N. A clinical and systologic study of 37 cases of immunoglobulin A associated vasculitis. Am J Dermatopathol 1999; 21(3): 234–40
Rostoker G. Le purpura rhumatoïde. In: Kahn MF, Peltier AP, Meyer O, et al., editors. Maladies et syndromes systemiques. Paris: Flummarion, 2000: 801–36
Savel Ph, Perroud AM, Levy-Klotz B, et al. Vasculite leucocytoclasique et lymphocytaire des petits vaisseaux cutanés. Ann Dermatol Venereol 1982; 109: 503–12
Giancomo J, Tsai C. Dermal and glomerular deposition of IgA in anaphylactoid purpura. Am J Dis Child 1977; 131: 981–3
Gower R, Sams W, Thorne G, et al. Leucocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol 1977; 69: 477–84
Soter N, Mihm M, Gigli I, et al. Two distinct patterns in cutaneous necrotizing angiitis. J Invest Dermatol 1976; 66: 344–50
Zax R, Hodge S, Callen J. Cutaneous leukocytoclastic vasculitis: serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol 1990; 126: 69–72
Piette W, Stone M. A cutaneous sign of IgA-associated small dermal vessel leukocytoclastic vasculitis in adults (Henoch-Schönlein purpura). Arch dermatol 1989; 125: 53–6
Gerke P, Kruger S, Steinhoff J. Henoch-schönlein purpura cryofibrinogenemia and peripheral gangrene. Nephrol Dial Transplant 1999; 14: 1746–9
Catalano C, Fabbian F, Bordin V, et al. Failure of cyclosporine A in Controlling Schoenlein-Henoch purpura. Nephrol Dial Transplant 1998; 13: 1605–6
Hakim A. A rush of HSP cases. J Pediatr Gastroenterol Nutr 2000; 31: 324–5
Wohlfarth B, Asamer H. Symptoms and immunology of the Henoch-Schönlein syndrome. Arch Derm Res 1976; 255: 251–8
Van Hale H, Gibson L, Schroeter A. Henoch-Schönlein vasculitis: direct immunofluorescence study of uninvolved skin. J Am Acad Dermatol 1986; 15: 665–70
Smoller B, McNutt S, Contreras F. The natural history of vasculitis. Arch Dermatol 1990; 126: 84–9
Héné R, Velthuis P, Van de Wiel A, et al. The relevance of IgA deposits in vessel walls of clinically normal skin. Arch Intern Med 1986; 146: 745–9
Helander S, De Castro F, Gibson L. Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis. Acta Derm Venereol Suppl. (Stockh) 1995; 75: 125–9
Morel P, Crickx B, Civatte J. Signification de la fluorescence des vaisseaux du derme superficiel et moyen. Ann Dermatol Venereol 1980; 107: 507–13
Tekin M, Yalçinkaya F, Turner N, et al. Familial mediterranean fever: renal involvement by disease other than amyloid. Nephrol Dial Transplant 1999; 14: 475–9
Feldt R, Stickler G. The gastro-intestinal manifestations of anaphylactoid purpura in children. Staff Meetings of the Mayo Clinic 1962; 37: 465–73
Lin SJ, Chao H-C, Huang J-L. Gastrointestinal involvement as the initial manifestation in children with Henoch-Schönlein purpura-Clinical analysis of 27 cases. Acta Paediatr Sin 1998; 39: 186–90
Kato S, Shibuya H, Naganuma H, et al. Gastro-intestinal endoscopy in Henoch-Schönlein purpura. Eur J Pediatr 1992; 151: 482–4
Kato S, Ebina K, Maganuma H. Intestinal IgA deposition in Henoch-Schönlein purpura with gastro-intestinal manifestation. Eur J Pediatr 1996; 155: 91–5
Touchard G, Maire P, Beauchant M, et al. Vascular IgA and C3 deposition in gastro-intestinal tract of patients with henoch-Schönlein purpura. Lancet 1983; i: 771–2
Salliere D, Segond P, Grange MJ, et al. Manifestations digestives sévères du purpura rhumatoide de l’adulte. Sem Hop 1982; 58: 69–72
Chapoy P, Guidon MJ, Louchet E. Complications duodénales du purpura rhumatoïde. Gastroenterol Clin Biol 1984; 8: 604–8
Choong CK, Beasley SW. Intraabdominal manifestations of Henoch-schönlein purpura. J Pediatr Child Health 1998; 34: 405–9
Couture A, Veyrac C, Baud C, et al. Evaluation of abdominal pain in Henoch-Schönlein purpura by high-frequency ultrasound. Pediatr Radiol 1992; 22: 12–7
Jeong YK, Ha HK, Yoon CH, et al. Gastrointestinal involvement in Henoch-Schönlein syndrome: CT findings. AJR Am J Roentgenol 1997; 168: 965–8
Nota M, Gökemeijer J, Van der Laan J. Clinical usefulness of abdominal CT-scanning in Henoch-Schönlein vasculitis. Neth J Med 1995; 46: 142–5
Ösdemir H, Isik S, Buyan N, et al. Sonographic demonstration of intestinal involvement in Henoch-Schönlein syndrome. Eur J Radiol 1995; 20: 32–4
Shirahama M, Umeno Y, Tomimasu R, et al. The value of colour Doppler ultrasonography for small bowel involvement of adult Henoch-Schönlein purpura. Br J Radiol 1998;71: 788–91
Diaz C. Schönlein-Henoch purpura and pancreatitis. Dig Dis Sci 1995; 40: 750–1
Altinors N, Cepoglu C. Surgical treated intracerebral hematoma in a child with Henoch-Schönlein purpura. J Neurosurg Sci 1991; 35: 47–9
Cho CS, Min JK, Park SN, et al. Protein losing enteropathy associated with Henoch-Schönlein purpura in a patient with rheumatoid arthritis. Scand J Rheumatol 1996; 25: 334–6
Archimandritis A, Kalos A, Pantzos A, et al. Hemorrhagic ascites in a patient with anaphylactoid purpura. J Clin Gastroenterol 1994; 18: 257–8
White R. Henoch-Schönlein nephritis: a disease with significant late sequelae. Nephron 1994; 68: 1–9
Hughes F, Wolfish N, McLaine P. Henoch-Schönlein syndrome and IgA nephropathy: a case report suggesting a common pathogenesis. Pediatr Nephrol 1988; 2: 389–92
Silverstein D, Greifer I, Folkert V, et al. Sequential occurrence of IgA nephropathy and Henoch-Schönlein purpura: support for common pathogenesis. Pediatr Nephrol 1994; 8: 752–3
Rai A, Nast C, Adler S. Henoch-Schönlein purpura nephritis. J Am Soc Nephrol 1999; 10: 2637–44
Schärer K, Krmar R, Querfeld U, et al. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999; 13: 816–23
Nakamoto Y, Asano Y, Dohi K, et al. Primary IgA glomerulo-nephritis and Schönlein-Henoch purpura nephritis: clinico-pathological and immuno-histological characteristics. Q J Med 1978; 47: 495–516
Royer P, Habib R, Mathieu H, et al. Etude anatomo-clinique de 15 observations de néphropathies du purpura rhumatoïde. Ann Pédiatr (Paris) 1963; 39: 605–20
Urizar R, Michael A, Sisson S, et al. Anaphylactoid purpura II. Immunofluorescent and electron microscopic studies of glomerular lesions. Lab Invest 1968; 19: 437–50
Vogler C, Eliasm S, Wood E. Glomerular membranopathy in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatric Dev Pathol 1999; 2: 227–35
Ferrario F, Castiglione A, Colasanti G, et al. The detection of monocytes in human glomerulonephritis. Kidney International 1985; 28: 513–9
Mrowka C, Heintz B, Sieberth HG. VCAM1, ICAM1 and E-selectin in IgA nephropathy and Schönlein-Henoch purpura syndrome: difference between tissue expression and serum concentrations. Nephron 1999; 81: 256–63
Matsuda M, Shikata K, Makino H, et al. Gene expression of PDGF and PDGF receptor in various form of glomerulonephritis. Am J Nephrol 1997; 17: 25–31
Urizar R, Singh J, Muhammad T, et al. Henoch-Schönlein anaphylactoid purpura nephropathy: electron microscopy lesions mimicking acute post-streptococcal nephritis. Human Pathol 1978; 19: 223–9
West C, McAdams J, Welch T. Glomerulonephritis in Henoch-Schönlein purpura without mesangial deposition. Pediatr Nephrol 1994; 8: 677–83
Jardim H, Leake J, Ridson A, et al. Crescentic glomerulonephritis in children. Pediatr Nephrol 1992; 6: 231–5
Lee K, Rao V, Franklin W, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Human Pathol 1982; 13: 314–22
Rostoker G, Desvaux-Belghiti D, Pilatte Y, et al. High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med 1994; 120 476–84
Koskimies O, Rapola J, Salivahti E, et al. Renal involvement in Schönlein-Henoch purpura. Acta Paediatr Scand 1974; 63: 357–63
Meadow SR. The prognosis of Henoch-Schoenlein nephritis. Clin Nephrol 1978; 9: 87–90
Foster B, Bernard C, Drummond K, et al. Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 2000; 136: 370–5
Coppo R, Mazzucco Y, Cagnoli L, et al. Long term prognosis of Henoch-schönlein nephritis in adults and children. Nephrol Dial Transplant 1997; 12: 2277–83
Counahan R, Winterborn M, White R, et al. Prognosis of Henoch-Schönlein nephritis in children. BMJ 1977; 2: 11–4
Niaudet P, Habib R. Schönlein-Henoch purpura nephritis: prognostic factors and therapy. Ann Med Interne (Paris) 1994; 145: 577–80
Iijima K, Ito-Kariya S, Nakamura H, et al. Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 1998; 12: 244–8
Linné T, Aperia A, Broberger O, et al. Renal function and biopsy changes during the course of Henoch-Schönlein glomerulonephritis. Acta Paediatr Scand 1983; 72: 97–104
Niaudet P, Levy M, Broyer M, et al. Clinicopathologic correlations in severe forms of Henoch-Schönlein purpura nephritis based on repeat biopsies. Contrib Nephrol 1984; 40: 250–4
Niaudet P, Habib R. Methyl prednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 1998; 12: 238–43
Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein purpura. Pediatr Nephrol 1995; 9: 6–10
Rostoker G, Desvaux-Belghiti D, Pilatte Y, et al. Immunomodulation with low-dose immunoglobulin for moderate IgA nephropathy and Henoch-Schönlein purpura: preliminary results of a prospective uncontrolled trial. Nephron 1995; 69: 327–34
Burke E, Mills S, Stickler G. Nephritis associated with anaphylactoid purpura in childhood: clinical observation and prognosis. Mayo Clin Proc 1960; 35: 641–52
Goldstein A, Akuse R, White R, et al. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992; 339: 380–2
Hasegawa A, Kawamura T, Ito H. Fate of renal grafts with recurrent Henoch-Schönlein purpura nephritis in children. Transplant Proc 1989; 21: 2130–3
Meulders Q, Pirson Y, Cosyns JP, et al. Course of Henoch-Schönlein nephritis after renal transplantation. Transplantation 1994; 58: 1179–86
Chamberlain R, Greenberg L. Scrotal involvement in Henoch-Schönlein purpura: a case report and review of the literature. Pediatr Emerg Care 1992; 8: 213–5
Ben-chaim J, Korat E, Shenfeld O, et al. Acute scrotum caused by Henoch-schönlein purpura with immediate response to short term steroid therapy. J Pediatr Surg 1995; 30: 1509–10
Kher KK, Sheth K, Makker SP. Stenosis ureteritis in Henoch-Schönlein purpura. J Urol 1983; 129: 1040–2
Ghali N, Voisin PM, Diallo D, et al. Hemosidérose pulmonaire au cours d’un purpura rhumatoïde de l’adulte. Nephrologie 1994; 15: 233
Kathuria S, Chejfec G. Fatal pulmonary Henoch-Schönlein syndrome. Chest 1982; 82: 654–6
Olson J, Kelly K, Pan C, et al. Pulmonary disease with hemorrhage in Henoch-Schönlein purpura. Pediatrics 1992; 89: 1177–81
Palier A, Kelly K, Sethi R. Pulmonary hemorrhage: an often fatal complication of Henoch-Schönlein purpura. Pediatric. Dermatol. 1997; 14: 299–302
Green RJ, Ruoss SJ, Kraft SA, et al. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 1996; 110(5): 1305–16
Hammoudeh M, Qaddoumi NK. Pleural hemorrhage in Henoch-Schönlein purpura. Clin Rheumatol 1993; 12: 538–9
Chaussain M, De Boissieu D, Kalifa G, et al. Impairment of lung diffusion in Schönlein-Henoch purpura. J Pediatr 1992; 121: 12–6
Delhumeau A, Cavellat JF, Granry JC, et al. Tamponnade cardiaque au cours d’un purpura rhumatoide. Ann Fr Anesth Reanim 1982; 1: 183–5
Lamy A, Rifle G, Guillaumie J, et al. Purpura rhumatoide de l’adulte: pericardite aigüe intermittente. Presse Med 1973; 2: 2276
Abdel-Hadi O, Hartley R, Grenstone M, et al. Myocardial infarction: a rare complication in Henoch-Schönlein purpura. Postgrad Med J 1981; 57: 390–2
McGregor G. Cardiac involvement in anaphylactoid purpura. Lancet 1957; 2: 572–5
Ostergaard J, Storm K. Neurologic manifestations of Schönlein-Henoch purpura. Acta Paediatr Scand 1991; 80: 339–42
Belman A, Leicher C, Moshé S, et al. Neurologic manifestations of Schönlein-Henoch purpura; report of three cases and review of literature. Pediatrics 1985; 75: 687–92
Fielding RE, Hawkins CP, Hand MF, et al. Seizures complicating adult Henoch-Schönlein purpura. Nephrol Dial Transplant 1998; 13: 761–2
Ng CC, Huang SC, Huang LT. Henoch-Schönlein purpura with intracerebral hemorrhage: case report. Pediatr Radiol 1996; 26: 276–7
Ha TS, Cha SH. Cerebral vasculitis in Henoch-schönlein purpura: a case report with sequential magnetic resonance imaging. Pediatr Nephrol 1996; 10: 634–6
Yamabe H, Ozawa K, Fukushi K, et al. IgA nephropathy and Henoch-Schönlein purpura nephritis with anterior uveitis. Nephron 1988; 50: 368–70
Cull D, Rosario V, Lally K, et al. Surgical implications of Henoch-Schönlein purpura. J Pediatr Surg 1990; 25: 741–3
Martinez-Frontanilla L, Haase G, Ernster J, et al. Surgical complications in Henoch-Schönlein purpura. J Pediatr Surg 1984; 19: 434–6
Bailey H. The acute non surgical abdomen of Henoch-Schönlein syndrome in the elderly patient. Br J Surg 1930; 18: 234–40
Blakeloch R, Beasley S. The clinical implications of an idiopathic intussusception. Pediat Surg Int 1998; 14: 163–7
Gow K, Murphy J, Blair G, et al. Multiple entero-entero-fistulae: an unusual complication of Henoch-Schönlein purpura. J Pediatr Surg 1996; 31: 809–11
Van den Broek R, Van Rossum M, Van Duinen C. Anew surgical complication related to corticosteroids in patients with Henoch-Schönlein purpura. J Pediatr Surg 1995; 30: 1341–3
De Mattia D, Penza R, Giordano P, et al. Von Willebrand factor and factor XIII in children with Henoch-Schönlein purpura. Pediatr Nephrol 1995; 9: 603–5
Lin S-C, Tsai M-J, Huang M-T, et al. Immunological studies of children with anaphylactoid purpura. Acta Paediatr Sin 1998; 39: 247–52
Le Goff C, Chatelier C, Lobbedez T, et al. Purpura rhumatoïde au cours d’une grossesse. Néphrologie 1997; 18: 27–9
Merrill J, Lahita R. Henoch-Schönlein purpura remitting in pregnancy and during sex steroid therapy. Br J Rheumatol 1994; 33: 586–8
Leavitt R, Fauci A. Polyangiitis overlap syndrome. Am J Med 1986; 81: 79–85
Ozdogan H, Arisoy N, Kasapçapur O, et al. Vasculitis in familial Mediterranean fever. J Rheumatol 1997; 24: 323–7
Finkel T, Török K, Ferguson P, et al. Chronic parvovirus B-19 infection and systemic necrotizing vasculitis: opportunistic infection or aetiological agent. Lancet 1994; 1: 1255–8
Challine-Lehman D, Mauberquez S, Pawlotsky JM, Rostoker G. Parvovirus B-19 and schönlein-Henoch purpura in adults. Nephron 1999; 83: 172
Ferguson P, Saulsburry F, Dowell SF, et al. Prevalence of human parvovirus B-19 infection in children with Henoch-schönlein purpura. Arthritis Rheum 1996; 39: 880–2
Minohara Y. Studies on the relationship between anaphylactoid purpura and human parvovirus B19. Kausenhogan Ku Zusshi 1995; 69: 928–33
Riavis M, Volanthen R, Bianchetti M. Testing for parvovirus in Henoch-Schönlein syndrome. Paediatr Dermatol 1998; 15: 71
Mattoo T, Al Mutain A, Al-Khatiby Y, et al. Group A haemolytic streptococcal infection and Henoch-Schönlein purpura with cardiac, renal and neurological complications. Ann Trop Pediatr 1997; 17: 381–6
Robson WL, Leung A. The frequency of proceeding infection with group A B haemolytic streptococcus in patients with Henoch-Schönlein purpura. J Singapore Paediatr Soc 1993; 35: 168–71
Mathé G. Syndrome de Schönlein-Henoch. Rev Prat 1954; 4: 2899–910
Bouissou H, Dupont H, Regnier H. L’atteinte rénale au cours du syndrome de Schönlein-Henoch: étude clinique, étude histologique par ponction biopsie du rein. Arch Franc Pediatr 1959; 16: 890–914
Piette W. What is Schönlein-Henoch purpura and why should we care? Arch Dermatol 1997; 133: 515–8
Mills J, Michel B, Bloch A, for the American College of Rheumatology, subcommittee on classification of vasculitis. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114–21
Watts R, Joliffe V, Grattan C, et al. Cutaneous vasculitis in a defined population. Clinical and epidemiological associations. J Rheumatol 1998; 25: 920–4
Legrain V, Lejean S, Taïeb A, et al. Infantile acute hemorrhagic oedema of the skin: study of ten cases. J Am Acad Dermatol 1991; 24: 17–22
Amitai Y, Gillis D, Wasserman D, et al. Henoch-Schönlein purpura in infants. Pediatrics 1993; 92: 865–7
Athreya B. Vasculitis in children. Pediatr Rheumatol 1995; 42: 1239–61
Fauci A. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978; 89: 660–76
Israel L, Mathé G, Bernard J. Purpura capillaire provoqué chez le cobaye par des immuns-serum de lapin anti-endothélium de cobaye. Sang 1950; 36: 603–5
Jennette C, Wieslander J, Tuttle R, et al. Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. Am J Kidney Dis 1991; 18: 466–71
Warenbourg H, Goudemand M, Niquet G, et al. Purpura rhumatoïde avec hypogammaglobulinémie. Lille Med 1963; 8: 457–60
Brouet JC, Clauvel JP, Danon F, et al. Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1975; 57: 775
Agnello V, Chung R, Kaplan L. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490–5
Madridano Cobo O, Sendino Revuelta A, Martinez Hernandez PL, et al. Sindrome poliangeitico de solapamiento purpura de Schönlein Henoch-PAN: un caso mas de una rara asociacion. An Med Intern (Madrid) 1995; 12: 195–6
Martin SJ, Audrain MA, Baranger T, et al. Recurrence of immunoglobulin A nephropathy with Immunoglobulin A anti-neutrophil cytoplasmic antibodies following renal transplantation. Am J Kidney Dis 1997; 29: 125–31
Ramirez SB, Rosen S, Niles J, et al. IgG anti-neutrophil cytoplasmic antibodies in IgA nephropathy: a clinical variant. Am J Kidney Dis 1998; 31: 341–4
Ronda N, Esnault L, Lay ward L, et al. Antineutrophil cytoplasm antibodies of IgA isotype in Adult Henoch-Schönlein purpura. Clin Exp Immunol 1994; 95: 49–55
Garber M, Mohr B, Calabrese H. Henoch-schönlein purpura associated with anti-RO, anti-phospholipid antibody syndrome. J Rheumatol 1993; 20: 1964–6
Galan J, Timoney J. immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcusequi. J Immunol 1985; 135: 3134–7
Khoury S, Hanckok W, Weiner H. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down regulation of inflammatory cytokines and differential up regulation of transforming growth factor-β, interleukin 4 and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355–64
Urizar R, Schwartz A, VerniervR. Immunofluorescence microscopy and ultrastructural changes of kidney in experimental anaphylactoid purpura. Lab Invest 1969; 21: 77–84
Bernard J. Le syndrome de Schönlein-Henoch: étude expérimentale et clinique. Brux Med 1957; 65: 1219–32
Oliviera D. IgA-related glomerulopathies. In: Oliviera D, editor. Immunological aspect of renal disease. Cambridge: Cambridge University Press, 1992: 87–113
Tomino Y, Sakai H, Endoh M, et al. Cross-reactivity of eluted antibodies from renal tissues of patients with Henoch-Schönlein purpura nephritis and IgA nephropathy. Am J Nephrol 1983; 3: 315–8
Saulsbury F. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J Rheumatol 1997; 24: 2246–9
Allen AC, Willis FR, Beattie TJ, et al. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13: 930–4
Allen AC, Harper SJ, Feehally J. Galactosylation of N and O-linked carbohydrate moieties of IgAl and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470–4
Mestecky J, Tomana M, Crowley-Nowick PA. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172–82
Trygstad C, Stiehm R. Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics 1971; 47: 1023–8
Moja PH, Quesnel A, Resseguier V, et al. Is there IgA from gut mucosal origin in the serum of children with Henoch-Schönlein purpura. Clin Immunol Immunopathol 1998; 86: 290–7
Garcia-Fuentes M, Chantler C, Williams G. Cryoglobulinemia in Henoch-Schönlein purpura. BMJ 1977; 2: 163–5
Jones C, Powell H, Kincaid-Smith P, et al. Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int 1990; 38: 323–31
Levinsky R, Barratt M. IgA immune complexes in Henoch-Schönlein purpura. Lancet 1979; ii: 1100–3
Danielsen H, Eriksen E, Johansen A, et al. Serum immunoglobulin sedimentation patterns and circulating immune complexes in IgA glomerulonephritis and Schönlein-Henoch nephritis. Acta Med Scand 1984; 215: 435–41
Kauffmann R, Herrmann W, Meyer C, et al. Circulating IgA-immune complexes in Henoch-Schönlein purpura. Am J Med 1980; 69: 859–66
Saulsbury F. The role of IgA1 rheumatoid factor in the formation of IgA-containing immune complexes in Henoch-Schönlein purpura. J Clin Lab 1987; 23: 123–7
Blanco-Quiros A, Blanco C, Alvarez J, et al. Anti-immunoglobulin antibodies in children with Schönlein-Henoch syndrome. Absence of serum anti-IgA antibodies. Eur J Pediatr 1994; 153: 103–6
Saulsbury F. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schönlein purpura. Arthritis Rheum 1992; 35: 1377–80
Tomana M, Matousovic K, Julian B, et al. Galactose deficient IgAl in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509–16
Rostoker G, Del Prato S, Petit-Phar M, et al. IgA anti-gliadin antibodies as a possible marker for IgA mesangial glomerulonephritis in adults with primary glomerulonephritis. N Engl J Med 1989; 320: 1283–4
Davin JC, Li Vecchi M, Mathieu P. No pathogenic role of enhanced plasma IgA binding capacity to fibronectin and IgA-fibronectin aggregates in Henoch-Schönlein purpura. Nephron 1996; 74: 435–6
Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schönlein purpura. Dermatology 1992; 184: 171–6
Smith G, Davidson J, Hughes D, et al. Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol 1997; 11: 477–80
Spitzer R, Urmson J, Farnett ML, et al. Alteration of the complement system in children with Henoch-Schönlein purpura. Clin Immunol Immunopathol 1978; 11: 52–9
Abou-Raghed H, Williams A, Brown C, et al. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis. Nephron 1992; 62: 22–6
Rifai A, Chen A, Imai H. Complement activation in experimental IgA nephropathy: an antigen-mediated process. Kidney Int 1987; 32: 838–44
Endo M, Hiroyuki O, Ohsawa I, et al. Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis. Am J Kidney Dis 2000; 35: 401–7
O’Donoghue D, Darvill A, Ballardie F. Mesangial autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura. J Clin Invest 1991; 88: 1522–30
O’Donoghue D, Jewkes F, Postlethwaite R, et al. Autoimmunity to glomerular antigens in Henoch-Schönlein nephritis. Clin Sci 1992; 83: 281–7
Fujieda M, Oishi N, Naruse K, et al. Soluble thrombo-modulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura. Arch Dis Child 1998; 78: 240–4
Besbas N, Saatci U, Ruacan S, et al. The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 1997; 26: 456–60
Furukawa S, Matsubara T, Yone K, et al. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumor necrosis factor-a and interleukin 6 in serum. Eur J Pediatrics 1992; 151: 44–7
Montinaro V, Hevey K, Aventaggiato L, et al. Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int 1992; 42: 341–53
Rostoker G, Rymer JC, Bagnard G, et al. Imbalances in serum pro-inflammatory cytokine and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy and Henoch-Schönlein purpura nephritis and a potential target of immunoglobulin therapy? Clin Exp Immunol 1998; 114: 468–76
Wu TH, Wu SC, Huang TP, et al. Increased excretion of tumor necrosis factor alpha and interleukin 1b in urine from patients with IgA nephropathy and Schönlein Henoch-purpura. Nephron 1996; 74: 79–88
Matsubara T, Umezawa Y, Tsuru S. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand J Rheumatol 1997; 26: 314–7
Burden D, Tillman D, Foley P, et al. IgA class anticardiolipin antibodies in cutaneous leucocytoclastic vasculitis. J Am Acad Dermatol 1996; 35: 411–5
Davin JC, Pierard G, Dechenne C, et al. Possible pathogenic role of IgE in Henoch-Schönlein purpura. Pediatr Nephrol 1994; 8: 169–71
Saulsbury F. Increased IgD concentrations in children. Br J Rheumatol 1998; 37: 570–2
Rostoker G, Pech MA, Del Prato S, et al. Serum IgG and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura. Clin Exp Immunol 1989; 75: 30–4
Besbas N, Erbay A, Saatçi U, et al. Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schönlein purpura. Clin Exp Rheumatol 1998; 16: 95–8
Söylemezoglu O, Sultan N, Gursel T, et al. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura. Arch Dis Child 1996; 75: 507–11
Casonato A, Pontara E, Bertomoro A, et al. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. Am J Hematol 1996; 51: 7–11
Henriksson P, Hedner U, Nilsson M. Factor XIII (fibrin stabilizing factor) in Henoch-Schönlein purpura. Acta Paediatr Scand 1977; 66: 273–7
Floege J, Burg M, Al Masri A, et al. Expression of interferon inducible Mx-proteins in patients with IgA nephropathy and Henoch-Schönlein purpura. Am J Kidney Dis 1999; 33: 434–40
Namgoong MK, Lim BK, Kim JS. Eosinophil cationic protein in Henoch-Schönlein purpura and IgA nephropathy. Pediatr Nephrol 1997; 11: 703–6
Turi S, Belch JJ, Beattie T, et al. Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura. Arch Dis Child 1986; 61: 173–7
Demircin G, Öner A, Ünver Y, et al. Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch-Schönlein purpura. Acta Paediatr 1998; 87: 848–52
Casanueva B, Rodriguez-Valverde V, Merino J, et al. increased IgA-producing cells in the blood of patients with active Henoch-Schönlein purpura. Arthritis Rheum 1983; 26: 854–60
Casanueva B, Rodriguez-Valverde V, Luceno A. Circulating producing cells in the differential diagnosis of Henoch-Schönlein purpura. J Rheumatol 1988; 15: 1229–33
Kuno-Sakai H, Sakai H, Nomoto Y, et al. Increase of IgA-bearing peripheral blood lymphocytes in children with Henoch-Schönlein purpura. Pediatrics 1979; 64: 918–22
Beale M, Nash G, Bertovich J, et al. Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus. J Immunol 1982; 128: 486–91
Bannister K, Drew P, Clarkson A, et al. Immunoregulation in glomerulonephritis, Henoch-Schönlein purpura, and lupus nephritis. Clin Exp Immunol 1983; 53: 384–90
Kondo N, Kasahara K, Shinoda S, et al. Accelerated expression of secreted alpha-chain gene in anaphylactoid purpura. J Clin Immunol 1992; 12: 193–6
Withworth JA, Leibowitz S, Kennedy MC, et al. IgA and glomerular disease. Clin Nephrol 1976; 5: 33–6
Davin JC, Mahieu P. Sequential measurements of intestinal permeability to Cr51EDTA in children with Henoch-Schönlein purpura nephritis. Nephron 1992; 60: 498–9
Béné MC, Hurault de Ligny B, Faure G, et al. Histo-immunological discrepancies in primary IgA nephropathy and anaphylactoid purpura sustain relationships between mucosa and kidney. Nephron 1986; 43: 214–6
Jin DK, Kohsaka T, Koo JW, et al. Complement 4 locus II gene deletion and DQA1*0301 gene: genetic risk factors for IgA nephropathy and Henoch-Schönlein nephritis. Nephron 1996; 73: 390–5
Mc Lean R, Wyatt R, Julian B. Complement phenotypes in glomerulonephritis: increased frequency of homozygotous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura. Kidney Int 1984; 26: 855–60
Mir S, Kutukculer N, Coker M, et al. Major histocompatibility complex antigens in Turkish children with Henoch-Schönlein purpura. Nephrol Dial Transplant 1994; 9: 596–7
Nathwani D, Laing R, Smith C, et al. Recurrent post-infective Henoch-Schönlein syndrome: a genetic influence related to HLA B 35. J Infection 1992; 25: 205–10
Amoroso A, Berrino M, Canale L, et al. Immunogenetics of Henoch-Schönlein disease. Eur J Immunogenet 1997; 24: 323–33
Liu ZH, Cheng ZH, Yu YS, et al. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy. Kidney Int 1997; 51: 1938–42
Amoroso A, Danek G, Vatta S, et al. Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schönlein patients. Nephrol Dial Transplant 1998; 13: 3184–8
Yoshioka T, Xu YX, Yoshida H. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 1998; 79: 394–9
Rostoker G, Lagrue G, Weil B. Le purpura rhumatoïde est-il la forme systèmique de la maladie de Berger: plaidoyer pour une conception uniciste. Rev Eur Dermatol 1990; 2: 323–7
Waldo B. Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 1988; 12: 373–7
Kessler H, Hiesse C, Hestin D, et al. Recurrence of Immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996; 28(1): 94–104
Levy M. Cas familiaux de maladie de Berger ou de maladie de Berger et de purpura rhumatoïde. Étude coopérative de la Société Française de Néphrologie. Néphrologie 1989; 10: 175–82
Bensman A, Refabert L. Un dogme non justifié: le repos strict dans le purpura rhumatoïde. Arch Fr Pediatr 1993; 50: 635–6
Prigent F, Chevallier B, Bensman A, et al. L’alitement, traitement du purpura rhumatoïde? Ann Dermatol Venereol 1997; 124: 296–8
Szer I. Henoch-Schönlein purpura when and how to treat. J Rheumatol 1996; 23: 1661–5
Narin N, Akçoral A, Aslin I, et al. Ranitidine administration in Henoch-Schönlein vasculitis. Acta Paediatr Jpn 1995; 37: 37–9
Jacqz-Aigrain E, Burtin P, Azevedo I, et al. Les corticoïdes: pharmacologie et indications des cures courtes en pédiatrie. Arch Pediatr 1995; 2: 353–64
Rostoker G. IX Néphrologie. In: Guillevin L, Le Parc M, Brion N, editors. Les corticoïdes et la corticotherapie. Paris: Masson, 1997:231–54
Philpott M, Briggs J. Treatment of the Schönlein Henoch syndrome with adrenocorticotrophic hormone (ACTH) and cortisone. Arch Dis Child 1953; 28: 57–601
Rosenblum N, Winter H. Steroid effects on the course of abdominal pain in children with Henoch-Schönlein purpura. Pediatrics 1987; 79: 1018–21
Mollica F, Li Volti S, Garozzo R, et al. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992; 151: 140–4
Saulsbury F. Corticosteroids therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1993; 7: 69–71
Temmel A, Emminger W, Schroth B, et al. Early prednisone treatment and nephropathy in anaphylactoid purpura. Eur J Pediatrics 1993; 152: 782–3
Buchanec J, Galanda V, Minarik M, et al. Can the nephropathy in Schönlein-Henoch purpura syndrome be prevented by early administration. Clin Nephrol 1987; 28: 156
Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schönlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 1998; 49: 9–14
Gianviti A, Trompeter RS, Barrat TM, et al. Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 1996; 75: 186–90
Kauffmann R, Houvert D. Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating immune complexes. Clin Nephrol 1981; 16: 155–60
Hattori M, Ito K, Kanomoto T, et al. Plasmapheresis as the role therapy for rapidly progressive Henoch-schönlein purpura in children. Am J Kidney Dis 1999; 33: 427–33
FaeddaR, Pirisi M, Satta A, et al. Regression of Henoch-Schönlein disease with intensive immunosuppressive treatment. Clin Pharmacol Ther 1996; 60: 576–81
Schmaldienst S, Winkler S, Breiteneder S, et al. Severe nephrotic syndrome in a patient with Henoch-Schönlein purpura complete remission after cyclosporin. Nephrol Dial Transplant 1997; 12: 790–2
Nguyen Tan Lung R, Granier M, Gaudry C, et al. Cyclophosphamide en cours de grossesse: une prescription acceptable. J Gynecol Obstet Biol Reprod (Paris) 1995; 24: 314–8
Fredenberg M, Malkinson F. Sulfone therapy in the treatment of leukocytoclastic vasculitis. J Am Acad Dermatol 1987; 16: 772–8
Chamouard P, Baumann R, Thomas G, et al. Intérêt de la dapsone dans le traitement des manifestations digestives du purpura rhumatoïde de l’adulte. Ann Med Interne 1987; 138: 599–600
Hoffbrand B. Dapsone in Henoch-Schönlein purpura: worth a trial. Postgrad Med J 1991; 67: 961–2
Ledermann J, Hoffbrand B. Dapsone in allergic vasculitis: its use in Henoch-Schönlein disease following vaccination. J R Soc Med 1983; 76: 613–4
Sarma P. Dapsone in Henoch-Schönlein purpura. Postgrad Med J 1994; 70: 464–5
Heldrich F, Minkin S, Gatdula C. Intravenous immunoglobulin in Henoch-Schönlein purpura: a case study. Maryland Med J 1993; 42: 577–9
Amjad H, Jafary H, Amjad LQ. The use of intravenous immune globulin as scavenger in immune complex vasculitis [abstract]. Clin Res 1993; 41: 362A
Hamidou M, Pottier MA, Dupas B. Intravenous Immunoglobulin in Henoch-Schönlein purpura. Ann Intern Med 1996; 125: 1013
Kusuda A, Misita K, Tsuboi M, et al. Successful treatment of adult onset Henoch-Schönlein purpura nephritis with high dose immunoglobulins. Int Med 1999; 38: 376–9
Ruellan A, Khatibi M, Staub T, et al. Purpura rhumatoïde et immunoglobulines intraveineuses. Rev Med Intern 1997; 18: 727–9
Blanco R, Gonzalez-Gay MA, Ibanez D, et al. Paradoxical and persistent renal impairment in Henoch-Schönlein purpura after high-dose immunoglobulin therapy. Nephron 1997; 76: 247–8
Rodriguez-Villarreal I, Ortega O, Vigil A, et al. Henoch-Schönlein nephritis. Adverse effect of treatment with intravenous immunoglobulin. Nephrol Dial Transplant 1999; 14: 795–6
Rostoker G, Phillipon C, Belghiti D, et al. Intravenous IgG for glomerulonephritis and renal function. Lancet 1991; II: 54–5
Kim PK, Kim KS, Lee JK, et al. Rifampicin therapy in Henoch-Schönlein purpura nephritis accompanied by nephrotic syndrome. Child Nephrol Urol 1988; 9: 50–6
Lee Y, Horstman L, Ahn Y. Danazol for Henoch-Schönlein purpura. Ann Intern Med 1993; 118: 827.87
Maeda H, Amatsu H, Tsuda M. Effects of tonsillectomy on juvenile nephritis, involving IgA nephropathy, purpura nephritis, and chronic and persistent glomerulonephritis. Nippon Jibinkoka Gakkai Kaiho 1986; 89: 1167–71
Utani A, Ohta M, Shinya A, et al. Successful treatment of adult Henoch-Schönlein purpura with factor XIII concentrate. J Am Acad Dermatol 1991; 24: 438–42
Watanabe T, Takahashi S, Nkajo S, et al. Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy. Acta Paediatr Jpn 1996; 38: 622–28
Acknowledgements
This work was supported by grants from Association Quincy Recherche Clinique et Thérapeutique, Centre Hospitalier Privé Claude Galien and Compagnie Génèrale de Santé. The author is grateful to Mrs Mireille Griuncelli for her technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rostoker, G. Schönlein-Henoch Purpura in Children and Adults. BioDrugs 15, 99–138 (2001). https://doi.org/10.2165/00063030-200115020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00063030-200115020-00004